Is metformin therapy for polycystic ovary syndrome safe during pregnancy?

Basic and Clinical Pharmacology and Toxicology

Volumn 96, Issue 6, 2005, Pages 410-412

  Brock, Birgitte ^a,b   Smidt, Kamille ^a   Ovesen, Per ^a   Schmitz, Ole ^a   Rungby, Jørgen ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE; INSULIN; METFORMIN; SULFONYLUREA;

ABDOMINAL DISTENSION; AMENORRHEA; ANENCEPHALUS; ANOPHTHALMIA; ANOREXIA; ANOVULATION; BLOOD PLACENTA BARRIER; BREAST MILK; CHONDRODYSPLASIA; CLINICAL TRIAL; CONCEPTION; CONGENITAL MALFORMATION; DIARRHEA; DRUG ABSORPTION; DRUG BINDING; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; DRUG TRANSPORT; DRUG USE; GASTROINTESTINAL DISEASE; GLUCOSE METABOLISM; GROWTH RETARDATION; HUMAN; INFERTILITY; INSULIN RESISTANCE; LIPID METABOLISM; MALABSORPTION; META ANALYSIS; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PERINATAL MORTALITY; PLACENTAL TRANSFER; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY RATE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH; TASTE DISORDER; TERATOGENICITY; VOMITING;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ANENCEPHALY; ANIMALS; ANOPHTHALMOS; BLASTOCYST; FEMALE; FERTILITY; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; OVULATION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME;

EID: 20644452252     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_96602.x     Document Type: Short Survey

References (20)

1. Balen, A.: Polycystic ovary syndrome and cancer. Hum. Reprod Update 2001, 7, 522-525.
2. Bedaiwy, M. A., K. F. Miller, J. M. Goldberg, D. Nelson & T. Falcone: Effect of metformin on mouse embryo development. Fertil. Steril. 2001, 76, 1078-1079.
3. Ben Haroush, A., Y. Yogev & B. Fisch: Insulin resistance and metformin in polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 115, 125-133.
4. Biochemie GmbH. http://www.produktresume.dk/docushare/dscgi/ds.py/Get/ File-19341/Metformin_Biochemie,_filmovertrukne_tablet-ter_500_mg_og_800_mg.doc
5. De Fronzo, R. A., E. Ferrannini, H. Keen & P. Zimmer: International textbook of diabetes mellitus. Third edition. John Wiley & Sons Ltd., Chichester, West Sussex, 2004.
6. Denno, K. M. & T. W. Sadler: Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis. Teratology 1994, 49, 260-266.
7. Elliott, B. D., O. Langer & F. Schuessling: Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin. Amer. J. Obstet. Gynecol. 1997, 176, 527-530.
8. Gardiner, S. J., C. M. Kirkpatrick, E. J. Begg, M. Zhang, M. P. Moore & D. J. Saville: Transfer of metformin into human milk. Clin. Pharmacol. Therap. 2003, 73, 71-77.
9. Glueck, C. J., H. Phillips, D. Cameron, L. Sieve-Smith & P. Wang: Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil. Steril. 2001, 75, 46-52.
10. Hague, W. M., P. M. Davoren, J. Oliver & J. Rowan: Contraindications to use of metformin. Metformin may be useful in gestational diabetes. Brit. Med. J. 2003, 326, 762.
11. Hale, T. W., J. H. Kristensen, L. P. Hackett, R. Kohan & K. F. Ilett: Transfer of metformin into human milk. Diabetologia 2002, 45, 1509-1514.
12. Hellmuth, E., P. Damm & L. Molsted-Pedersen: Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet. Med. 2000, 17, 507-511.
13. Jakubowicz, D. J., M. J. Iuorno, S. Jakubowicz, K. A. Roberts & J. E. Nestler: Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2002, 87, 524-529.
14. Laven, J. S., B. Imani, M. J. Eijkemans & B. C. Fauser: New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet. Gynecol. Surv. 2002, 57, 755-767.
15. Legro, R. S.: Diabetes prevalence and risk factors in polycystic ovary syndrome. Obstet. Gynecol. Clin. North Amer. 2001, 28, 99-109.
16. Lord, J. M., I. H. Flight & R. J. Norman: Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Brit. Med. J. 2003, 327, 951-953.
17. Miao, J. & I. W Smoak: In vitro effects of the biguanide, metformin, on early-somite mouse embryos. Teratology 1994, 49, 389 (abstract).
18. Riman, T., S. Nilsson & I. R. Persson: Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta OBstet. gynecol. Scand. 2004, 83, 783-795.
19. Smoak, I. W.: Alteration of glucose metabolism by OHAs in early-somite mouse embryos in vitro. Teratology 1996, 53, 121-122 (abstract).
20. Tuchmann-Duplessis, H. & L. Mercier-Parot: Repercussions sur la gestation et le developpement foetal du rat d'un hypoglycemiant, le chlorhydrate de N,N-dimethylbiguanide. C. R. Acad. Sci. (Paris) 1961, 253, 321-323.